Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides

ClinicalTrials.gov ID: NCT02261493

Public ClinicalTrials.gov record NCT02261493. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 11:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a safety and efficacy study of onabotulinumtoxinA in subjects with upper facial rhytides (forehead lines, glabellar lines, lateral canthal lines \[crow's feet lines\]).

Study identification

NCT ID
NCT02261493
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Allergan
Industry
Enrollment
787 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 27, 2014 (Actual)
Primary completion
Jun 3, 2015 (Actual)
Completion
Apr 20, 2016 (Actual)
Last update posted
Jul 25, 2017

2014 – 2016

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
The Petrus Center for Aesthetic Little Rock Arkansas 72205 —
Westside Aesthetics Los Angeles California 90025 —
Eye Research Foundation Newport Beach California 92663 —
Steve Yoelin, MD Medical Associates, Inc. Newport Beach California 92663 —
Baumann Cosmetic & Research Institute Miami Florida 33137 —
Saint Louis University St Louis Missouri 63122 —
The Center For Dermatology Cosmetic and Laser Surgery Mount Kisco New York 10549 —
Tennessee Clinical Research Center Nashville Tennessee 37215 —
The Center for Skin Research Houston Texas 77056 —
Premier Clinical Research Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02261493, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 25, 2017 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02261493 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →